Cargando…

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review

BACKGROUND: Orally administrated agents play a key role in the management of prostate cancer, providing a convenient and cost-effective treatment option for patients. However, they are also associated with adherence issues which can compromise therapeutic outcomes. This scoping review identifies and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleshner, Neil E., Alibhai, Shabbir M. H., Connelly, Kim A., Martins, Ilidio, Eigl, Bernhard J., Lukka, Himu, Aprikian, Armen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064469/ https://www.ncbi.nlm.nih.gov/pubmed/37007631 http://dx.doi.org/10.1177/17588359231152845

Ejemplares similares

Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
por: Winquist, Eric, et al.
Publicado: (2006)

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
por: Kapoor, Anil, et al.
Publicado: (2019)

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT
por: Alibhai, Shabbir M. H., et al.
Publicado: (2018)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
por: Hu, Jason, et al.
Publicado: (2022)

Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer
por: Warner, Andrew, et al.
Publicado: (2015)

Prehabilitation for men undergoing radical prostatectomy: a multi-centre, pilot randomized controlled trial
por: Santa Mina, Daniel, et al.
Publicado: (2014)

Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways
por: Rashid, Ayesha, et al.
Publicado: (2011)

Oral contraceptive use is associated with prostate cancer: an ecological study
por: Margel, David, et al.
Publicado: (2011)

Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer
por: Alibhai, Shabbir M. H., et al.
Publicado: (2021)

The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer—A Systematic Literature Review with Application to the Canadian Context
por: Yanev, Ivan, et al.
Publicado: (2022)

Optimal Management of High-Risk T1G3 Bladder Cancer: A Decision Analysis
por: Kulkarni, Girish S, et al.
Publicado: (2007)

Does nerve-sparing radical prostatectomy increase the risk of positive surgical margins and biochemical progression?
por: Alkhateeb, Sultan Saud, et al.
Publicado: (2010)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
por: Zakaria, Ahmed S., et al.
Publicado: (2018)

Improving ultrasound-based prostate volume estimation
por: Aprikian, Saro, et al.
Publicado: (2019)

Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model
por: Sanyal, Chiranjeev, et al.
Publicado: (2014)

Adherence to Mediterranean Diet, Physical Activity and Survival after Prostate Cancer Diagnosis
por: Di Maso, Matteo, et al.
Publicado: (2021)

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
por: Dragomir, Alice, et al.
Publicado: (2014)

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer
por: Derderian, Seta, et al.
Publicado: (2022)

Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes
por: Alibhai, Shabbir M. H., et al.
Publicado: (2022)

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012)

Care provided by older adult caregivers to a spouse in active cancer treatment: a scoping review
por: Donison, Valentina, et al.
Publicado: (2022)

Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
por: Rescigno, Pasquale, et al.
Publicado: (2022)

Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network
por: Grosset, Andrée-Anne, et al.
Publicado: (2019)

Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada
por: Blanc-Lapierre, Audrey, et al.
Publicado: (2015)

A Scoping Review to Assess Adherence to and Clinical Outcomes of Wearable Devices in the Cancer Population
por: Huang, Yaoru, et al.
Publicado: (2022)

Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review
por: Skrabal Ross, Xiomara, et al.
Publicado: (2018)

The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
por: Chevalier, Simone, et al.
Publicado: (2015)

A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol
por: Santa Mina, Daniel, et al.
Publicado: (2015)

The Effects of Serum from Prostate Cancer Patients with Elevated Body Mass Index on Prostate Cancer Cells In Vitro
por: Mora, Benjamin C, et al.
Publicado: (2015)

A narrative review of pelvic lymph node dissection in prostate cancer
por: Cheung, Douglas C., et al.
Publicado: (2020)

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
por: Clark, Roderick, et al.
Publicado: (2022)

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
por: Mahmud, S, et al.
Publicado: (2004)

Maximal androgen blockade for the treatment of metastatic prostate cancer—a systematic review
por: Lukka, H., et al.
Publicado: (2006)

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
por: Ouellet, Véronique, et al.
Publicado: (2018)

Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study
por: Toren, Paul, et al.
Publicado: (2013)

Factors associated with treatment adherence to mandibular advancement devices: a scoping review
por: van der Hoek, Liselotte H., et al.
Publicado: (2023)

Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen
por: Blumenstein, Brent, et al.
Publicado: (2013)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis
por: Jayalath, Viranda H., et al.
Publicado: (2022)

Redefining Hormone Sensitive Disease in Advanced Prostate Cancer
por: Hou, Xiaoyu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_06f98stds6nktjr646j5b0qs69